Total Visits

Views
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks555

Total Visits Per Month

January 2026February 2026March 2026April 2026May 2026June 2026July 2026
Higher relapse rate among HIV/HCV-coinfected patients receiving sofosbuvir/ledipasvir for 8 vs 12 weeks4027384053432

File Visits

Views
HCV-coinfected patients receiving.pdf107

Top country views

Views
United States133
Germany108
Singapore67
Hong Kong47
Ireland40
Brazil35
Vietnam30
Japan15
United Kingdom10
Spain8

Top cities views

Views
Frankfurt am Main99
Ashburn63
Hong Kong47
Dublin40
Council Bluffs14
San Jose12
Hanoi11
Singapore10
Ho Chi Minh City9
Seoul7